Ravi Ramjeesingh

Dr. Ravi Ramjeesingh is an Associate Professor in the Division of Medical Oncology at Dalhousie University’s Faculty of Medicine, with a joint appointment in the Department of Community Health and Epidemiology. He specializes in breast cancer, gastrointestinal cancers, and melanoma, with clinical and research interests spanning translational research, health services delivery, and oncology education. His academic career includes residency and fellowship training at Queen’s University and the University of Toronto.

Education:

• MD & PhD (University of Toronto)
• Internal Medicine Residency (Queen’s University)
• Medical Oncology Residency (Queen’s University)
• Clinical Trial Methodology Fellowship (NCIC Clinical Trials Group, Queen’s University)

Research Focus: Translational research on cancer treatments, health services optimization, and medical education innovation. Notable work includes studies on adjuvant chemotherapy timing and metformin’s role in colorectal cancer survival.

Awards:

• 2015–2016: Medical Oncology Teacher of the Year (Dalhousie)
• 2014: AACR Scholar-in-Training Award
• 2013–2015: CAMO-CIHR Fellowship Award

Advising/Grants: Sub-investigator roles in collaborative oncology research (2013–2015). Active in training residents and medical students in oncology via clinical and didactic education.

Labs/Teams: Engaged with the Nova Scotia Cancer Centre and NCIC Clinical Trials Group. Collaborates on multidisciplinary teams addressing cancer care delivery and clinical trial design.